Skip to main content
  • an Accelerating Medicines Partnership® (AMP®) program
Register or Renew Workbench

NEI Main Menu

  • Register or Renew Workbench
  • About
      • About AMP PD
      • AMP PD Use Cases
      • Contact Us
      • Glossary
      • Who we are
      • Contributor Spotlights
  • News & Updates
      • News & Updates
      • Release Updates
      • AMP PD Research Plan
      • News & Articles Archive
      • Publications Archive
  • Data
      • Data
      • Harmonized Data
        • Summary Data Dashboard
        • Whole Genome Data
        • Transcriptomics Data
        • Targeted Proteomics Data
        • Clinical Assessment Data
      • Federated Data
        • GP2 Cohort Dashboard
        • Genomic Data
  • Cohorts
      • Cohorts
      • Unified Cohorts
        • BioFIND
        • HBS
        • LBD
        • LCC
        • PDBP
        • PPMI
        • STEADY-PD3
        • SURE-PD3
      • Federated Cohorts
        • GP2
  • Tools
      • Terra Platform
      • SmartConverter Data Curation
      • Visualization Tools & Resources
  • Researchers
      • Knowledge Platform Governance
      • Register for AMP PD
      • Data Use Agreement
  • Portal Resources
      • How To & References
      • AMP PD Training Videos
      • Cloud Cost Guidelines
      • Cloud Architecture
      • Computing Guidelines
  • FAQs
Register or Renew Workbench

Accelerating Medicines Partnership® Parkinson's Disease

Collaborating toward biomarker discovery to advance the development of Parkinson’s disease therapies

Get the AMP PD story
Register for Access
Already registered? Log in
Unified AMP PD Cohorts

Unified AMP PD Cohorts

Before clinical trials for new treatments can begin, researchers need thousands of volunteers building datasets and biosample banks, using the latest analysis methods and technologies.

Meet the AMP PD Cohorts
Genomic Visualization
Parallel Coordinates

Methods for Data Analysis

AMP® PD gives researchers access to a large, harmonized dataset with:

  • common clinical and genomic data
  • select clinical- and genetic- population information

plus proprietary, research-developed applications for visualizing and harmonizing data

Explore the AMP PD datasets
Explore the Researcher Tools

News & Updates

Read latest news and updates related to AMP PD

  • AMP PD in the news
  • Advancements in research using AMP PD
  • Grant and funding opportunities
  • Program milestones and roadmap
View all News & Updates

Accelerating Medicine Partnership in Parkinson's Disease Webinar

AMP PD has officially launched and made available the first series of webinar training videos. These videos provide information on key concepts and live demonstrations, including: 

  • Signing up for access via the online portal
  • Overview of the Google Cloud Platform (GCP)
  • Interacting with AMP PD data via BigQuery
  • Researcher Workbench (Terra) deep-dive
  • Working with official AMP PD Workspaces
  • NIH STRIDES Cloud overview
Learn More

New Large-Scale Data Portal Will Promote Parkinson’s Treatment Development

The Accelerating Medicines Partnership (AMP) for Parkinson’s (PD) has opened a data portal with de-identified information from 4,298 Parkinson’s patients and healthy control subjects for use by scientists seeking new treatments for the progressive neurodegenerative disease.

Read More
Source:
Parkinson's News Today

Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease

The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease.

Read More
Source:
NIH NINDS Press Release: November 22, 2019

Massive NIH–industry project opens portals to target validation

Five years in, the US$360 million Accelerating Medicines Partnership is yielding tools to speed up drug discovery for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease.

Read More
Source:
Nature Reviews Drug Discovery 18, 240-242 (2019)

Accelerating research for Parkinson's disease

Despite considerable ongoing translational and clinical research efforts, no disease-modifying drugs have been approved for Parkinson's disease. The Accelerating Medicines Partnership Parkinson's disease (AMP PD) programme, launched on Jan 30, 2018, is the most ambitious initiative so far to find a cure for Parkinson's disease.

Read More
Source:
The Lancet Neurology; Volume 17, Issue 4, Page 289
Collaborate with AMP PD

Collaborate with AMP PD

  • Share data, methods, tools, and resources with the AMP PD community
  • Apply for research grants
Contribute to AMP PD Research
ACCELERATING MEDICINES PARTNERSHIP and AMP are registered service marks of the U.S. Department of Health and Human Services.

Footer Links

  • Contact us
  • Policy & Governance
  • Privacy Statement
  • Disclaimer
  • Site Map
  • Accessibility Policy
  • Reuse & Copyright
  • Glossary